Skip to main content

Cash

Trending Midterms Elections Politics Sports Culture Crypto Commodities Climate Economics Mentions Finance Tech & Science

Predict Live159 AccountSocial

MARKETS INVEST LIVE159

Product

Kalshi Pro Invest Markets Incentive program Small business hedging Institutions API & developers

Company

About Kalshi Research Blog Careers Policy Center Brand Kit

Help

Help Center FAQ Prediction markets Fee schedule Trading hours Regulatory Trust Center

© 2026 Kalshi Inc. · All rights reserved

Privacy Data Terms of Service Trading Prohibitions FAQ for Finance Professionals

Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.

Amgen (AMGN) earnings | Kalshi

Amgen

AMGN

ReportsNov 3, 2026 · time not confirmed

Fiscal periodNot stated

Market capNot available

Consensus EPSNot covered

Year-ago EPSNot available

Expected changeNot available

Quarterly markets

What will Amgen say during their next earnings call?

GLP-1 / GLP
100%
Dazodalibep
100%
Imfinzi / Durvalumab
100%
ESMO
100%
Eosinophilic
100%
Oral (3+ times)
100%
Artificial Intelligence (3+ times)
100%
Patent (2+ times)
100%
Tavneos
100%
Medicare
100%
Prolia (2+ times)
100%
Acquisition
100%

2 more words trade on this call